To evaluate the efficacy and safety of Panitumumab after progression on Cituximab in combination with Irinotecan-based chemotherapy (FOLFIRI) among patients with Metastatic Wild-type KRAS Colorectal Cancer: Data from CORECT registry

Trial Profile

To evaluate the efficacy and safety of Panitumumab after progression on Cituximab in combination with Irinotecan-based chemotherapy (FOLFIRI) among patients with Metastatic Wild-type KRAS Colorectal Cancer: Data from CORECT registry

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Panitumumab (Primary) ; Cetuximab; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2016 New trial record
    • 01 Sep 2016 Results assessing efficacy and safety of Panitumumab published in the Anticancer Research (2016).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top